Surface material, surface treatment and nanotechnology in cardiovascular stent development

EuroIntervention

Volumn 4, Issue , 2008, Pages C60-C62

  Sprague, Eugene A ^a   Pomeranz, Mark L ^b   Odess, Ilana ^c   Furnish, Simon M ^c   Granada, Juan F ^d  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Prescient Medical Incorporated   (United States)

^c ZM Engineering Consulting   (United States)

^d CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD VESSEL WALL; CARDIOVASCULAR PARAMETERS; CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; EQUIPMENT DESIGN; HUMAN; IN-STENT RESTENOSIS; NANOTECHNOLOGY; NONHUMAN; PRODUCT DEVELOPMENT; SMOOTH MUSCLE CELL; STENT THROMBOSIS; AORTA; CYTOLOGY; DRUG ELUTING STENT; GENETICS; PATHOLOGY; PHYSIOLOGY; RESTENOSIS; STATISTICS; SURFACE PROPERTY; VASCULAR ENDOTHELIUM;

VASCULAR CELL ADHESION MOLECULE 1;

AORTA; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; ENDOTHELIUM, VASCULAR; EQUIPMENT DESIGN; HUMANS; NANOTECHNOLOGY; SURFACE PROPERTIES; VASCULAR CELL ADHESION MOLECULE-1;

EID: 63149193857     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Axel DI, Kunert W, Goggelmann C, Oberhoff M, Herdeg C, Kuttner A, Wild DH, Brehm BR, Riessen R, Koveker G Karsch KR: Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation, 1997;96: 636-45.
2. Marx SO, Jayaraman T, Go LO Marks AR: Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ Res, 1995;76: 412-7.
3. Virmani R, Liistro F, Stankovic G, Di Mario C, Montorfano M, Farb A, Kolodgie FD Colombo A. Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans. Circulation, 2002;106: 2649-51.
4. Scott-Burden T Vanhoutte PM: The Endothelium as a Regulator of Vascular Smooth Muscle Proliferation. Circulation, 1993;87: V51-V55.
5. Haudenschild CC Schwartz SM: Endothelial regeneration. II. Restitution of endothelial continuity. Laboratory Investigation, 1979;41: 407-18.
6. Lev EI, Estrov Z, Aboulfatova K, Harris D, Granada JF, Alviar C, Kleiman NS Dong JF: Potential role of activated platelets in homing of human endothelial progenitor cells to subendothelial matrix. Thromb Haemost, 2006;96: 498-504.
7. Choudhary S, Haberstroh KM Webster TJ: Enhanced functions of vascular cells on nanostructured Ti for improved stent applications. Tissue Eng, 2007;13: 1421-30.
8. Lu J, Rao MP, Macdonald NC, Khang D Webster TJ: Improved endothelial cell adhesion and proliferation on patterned titanium surfaces with rationally designed, micrometer to nanometer features. Acta Biomater, 2008;4: 192-201.
9. Palmaz JC, Benson A Sprague EA: Influence of surface topography on endothelialization of intravascular metallic material. Journal of Vascular & Interventional Radiology, 1999;10: 439-44.
10. Bhargava B, Reddy NK, Karthikeyan G, Raju R, Mishra S, Singh S, Waksman R, Virmani R Somaraju B: A novel paclitaxel-eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: Evaluation in a porcine model. Catheter Cardiovasc Interv, 2006;67: 698-702.
11. Sprague EA Palmaz JC: A model system to assess key vascular responses to biomaterials. J Endovasc Ther, 2005;12: 594-604.
12. Wang G, Shen Y, Cao Y, Yu Q Guidoin R: Biocompatibility study of plasma-coated nitinol (NiTi alloy) stents. IET Nanobiotechnol, 2007;1: 102-6.
13. Wang GX, Shen Y, Zhang H, Quan XJ Yu QS: Influence of surface microroughness by plasma deposition and chemical erosion followed by TiO(2) coating upon anticoagulation, hydrophilicity, and corrosion resistance of NiTi alloy stent. J Biomed Mater Res A, 2007.
14. Arslan E, Igdil MC, Yazici H, Tamerler C, Bermek H Trabzon L: Mechanical properties and biocompatibility of plasma-nitrided laser-cut 316L cardiovascular stents. J Mater Sci Mater Med, 2007.
15. Sargeant TD, Rao MS, Koh CY Stupp SI: Covalent functionalization of NiTi surfaces with bioactive peptide amphiphile nanofibers. Biomaterials, 2008;29: 1085-98.
16. Chuang TW, Chen MH Lin FH: Preparation and surface characterization of HMDI-activated 316L stainless steel for coronary artery stents. J Biomed Mater Res A, (2007).
17. Aoki J, Serruys PW, van Beusekom H, Ong AT, McFadden EP, Sianos G, van der Giessen WJ, Regar E, de Feyter PJ, Davis HR, Rowland S Kutryk MJ: Endothelial progenitor cell capture by stents coated with antibody against CD34: The HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry. J Am Coll Cardiol, 2005;45: 1574-9. Initial clinical trial of a stent coated with a polymer-bound antibody to the CD34 antigen specific to circulating endothelial progenitor cells for treatment of coronary artery disease.
18. Rotmans JI, Heyligers JM, Verhagen HJ, Velema E, Nagtegaal MM, de Kleijn DP, de Groot FG, Stroes ES Pasterkamp G: In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts. Circulation, 2005;112: 12-8.
19. Szmitko PE, Kutryk MJ, Stewart DJ, Strauss MH Verma S. Endothelial progenitor cell-coated stents under scrutiny. Can J Cardiol, 2006;22: 1117-9.
20. Rotmans JI, Heyligers JM, Stroes ES Pasterkamp G: Endothelial progenitor cell-seeded grafts: Rash and risky. Can J Cardiol, 2006;22: 1113-6.